ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,689.74
0.44%
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs Yen
158.095
0.00%
Brent Oil
88.165
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Mainz BioMed NV (MYNZ)

  7. Mainz BioMed NV (MYNZ) ニュース

MYNZ Mainz BioMed NV

0.83
-0.0268 (-3.13%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Mainz BioMed NV MYNZ NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.0268 -3.13% 0.83 13:00:05
始値 安値 高値 終値 前日終値
0.8655 0.78 0.8794 0.8181 0.8568
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2522:29GLOBEMainz Biomed Reports Positive Topline Results from Pooled..
2024/4/0921:01GLOBEMainz Biomed Reports Full Year 2023 Financial Results
2024/3/1921:01GLOBEMainz Biomed Organizes HALLO DOC! Event to Highlight..
2024/3/1821:01GLOBEMainz Biomed: Webinar on Early Detection of Colorectal..
2024/3/1221:01GLOBEMainz Biomed Presents ColoAlert® at UDH Congress 2024:..
2024/3/0522:01GLOBEMainz Biomed Partners with Trusted Health Advisors to..
2024/2/2722:01GLOBEMainz Biomed to Showcase at the Gynecology Conference in..
2024/2/2222:01GLOBEMainz Biomed Announces Distribution Partnership with..
2024/2/2122:01GLOBEMainz Biomed Establishes Strategic Partnership with TomaLab..
2024/2/0622:01GLOBEMainz Biomed Establishes Physician-Led Laboratory Expanding..
2024/1/1122:01GLOBEMainz Biomed and TestDNA Drive CRC Innovation at the 10th..
2024/1/0922:01GLOBEMainz Biomed Provides Year-End Corporate Review 2023
2023/12/1922:01GLOBEMainz Biomed and Bantleon Partner to Elevate Corporate..
2023/12/1222:01GLOBEMainz Biomed Showcases ColoAlert® at Two Prominent..
2023/12/0523:01GLOBEMainz Biomed Reports Positive Topline Results from U.S...
2023/11/2922:01GLOBEMainz Biomed’s Presentation at the 35th Annual Piper Sandler..
2023/11/2022:01GLOBEMainz Biomed to Present at the 35th Annual Piper Sandler..
2023/11/1622:01GLOBEMainz Biomed Reports Third Quarter 2023 Financial Results..
2023/11/1523:01GLOBEMainz Biomed Announces Closing of $5.0 million Registered..
2023/11/1323:00GLOBEMainz Biomed Announces Pricing of $5.0 million Registered..
2023/11/0922:01GLOBEMainz Biomed Partners with Liquid Biosciences to Harness the..
2023/11/0722:01GLOBEMainz Biomed to Showcase ColoAlert® at Leading Global..
2023/10/3121:01GLOBEMainz Biomed Reports Success from Employee Colorectal Cancer..
2023/10/2621:01GLOBEMainz Biomed Appoints Tarrin Khairi-Taraki as VP of..
2023/10/1821:01GLOBEMainz Biomed Presents Groundbreaking Results of ColoFuture..
2023/10/1121:01GLOBEMainz Biomed to Showcase ColoAlert® at UEG Week 2023 in..
2023/10/0521:01GLOBEMainz Biomed to Attend the JonesTrading 2023 Healthcare..
2023/10/0421:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
2023/9/2721:01GLOBEMainz Biomed to Present Detailed Results of ColoFuture Study..
2023/9/2016:01GLOBEMainz Biomed to Present at the Cantor Fitzgerald Global..
2023/9/1316:01GLOBEMainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA..
2023/9/0516:01GLOBEMainz Biomed Announces Strategic Partnership with Ärztliches..
2023/8/2916:01GLOBEMainz Biomed to Present at the H.C. Wainwright Global..
2023/8/2216:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
2023/8/1519:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1516:01GLOBEMainz Biomed Announces Financial Half Year Results 2023 and..
2023/8/0116:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
2023/7/1816:01GLOBEMainz Biomed Announces Collaboration with Fugene Genetics in..
2023/7/1205:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/7/1205:15EDGAR2Form D - Notice of Exempt Offering of Securities
2023/6/2916:01GLOBEMainz Biomed Secures up to $50M in New Funding
2023/6/2905:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/6/2905:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/6/2816:01GLOBEMainz Biomed to Attend ESMO World Congress on..
2023/6/2016:01GLOBEMainz Biomed Expands into Romania Through Partnership with..
2023/5/3116:01GLOBEMainz Biomed Expands Commercial Footprint into Poland
2023/5/2416:01GLOBEMainz Biomed Processes First Patients from Colorectal Cancer..
2023/5/1616:01GLOBEMainz Biomed Announces First Quarter 2023 Financial Results..
2023/5/1016:01GLOBEMainz Biomed Partners with Microba Life Sciences for the..
2023/5/0316:01GLOBEMainz Biomed Announces Addition of Eurofins GeLaMed to its..

最近閲覧した銘柄

NASDAQ
MYNZ
Mainz BioMed NV
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有